Cerebral Mechanism of Tuina on the Descending Pain Inhibitory System in Knee Osteoarthritis: Protocol for a Randomized Controlled Trial

BackgroundKnee osteoarthritis (KOA) is reputedly the most common musculoskeletal disease of the lower limbs and the main cause of pain and disability among older individuals. Pain is the most significant and widespread symptom of KOA. The descending pain inhibitory system has...

Full description

Bibliographic Details
Main Authors: Hui Xu, Zheng Wang, Zhen Wang, Hang Zhou, Juan Guo, Wanyu Li, Yunfeng Zhou
Format: Article
Language:English
Published: JMIR Publications 2024-02-01
Series:JMIR Research Protocols
Online Access:https://www.researchprotocols.org/2024/1/e52820
_version_ 1797316381571547136
author Hui Xu
Zheng Wang
Zhen Wang
Hang Zhou
Juan Guo
Wanyu Li
Yunfeng Zhou
author_facet Hui Xu
Zheng Wang
Zhen Wang
Hang Zhou
Juan Guo
Wanyu Li
Yunfeng Zhou
author_sort Hui Xu
collection DOAJ
description BackgroundKnee osteoarthritis (KOA) is reputedly the most common musculoskeletal disease of the lower limbs and the main cause of pain and disability among older individuals. Pain is the most significant and widespread symptom of KOA. The descending pain inhibitory system has a cardinal role in normal pain consciousness, and its malfunction may be one of the pathophysiological mechanisms in KOA. Crucially, the rostral ventromedial medulla (RVM) and periaqueductal gray (PAG), as important components of the descending pain inhibitory system, directly modulate the activity of the spinal neurons involved in pain transmission. Tuina, a manual therapy, is effective and safe for reducing clinical symptoms of KOA; however, the mechanism that influences pain through the descending pain inhibitory system in KOA is unclear. ObjectiveThis study aims to investigate the modulatory implications of Tuina on the RVM and PAG, which have critical roles in the descending pain inhibitory system in patients with KOA. MethodsThis randomized controlled parallel trial will be conducted at the Tuina Clinic of the Third Affiliated Hospital of Henan University of Chinese Medicine (Zhengzhou, China). Patients with KOA will be randomly assigned (1:1) to 6 weeks of health education or Tuina. All patients in both groups will accept a resting-state functional magnetic resonance scan at the beginning and end of the experiment, and the resting-state functional connectivity and the voxel-based morphometry analysis will be performed to detect the RVM and PAG function and structure changes. The clinical outcome assessments will be (1) the pressure pain thresholds, (2) the Numerical Rating Scale, (3) the Hamilton Depression Scale (HAMD), and (4) the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Considering that this trial is a study of resting-state functional magnetic resonance imaging technology, resting-state functional connectivity and voxel-based morphometry are the primary outcomes, and clinical outcome assessments are secondary outcomes. Adverse events will be documented and assessed throughout. All main analyses will be carried out on the basis of the intention-to-treat principle. The outcome evaluators and data statisticians will be masked to the treatment group assignment to reduce the risk of bias. ResultsThis trial was approved by the ethics committee of the Third Affiliated Hospital of Henan University of Chinese Medicine. Enrollment began in December 2023, and the results of this trial are expected to be submitted for publication in May 2025. ConclusionsThis trial will identify a possible relationship between function and structure changes of RVM and PAG and the improvement of clinical variables, elucidating the effect of Tuina on the descending pain inhibitory system of patients with KOA. This trial will provide much-needed knowledge for Tuina for patients with KOA. Trial RegistrationChinese Clinical Trial Registry ChiCTR2300070289; https://www.chictr.org.cn/showproj.html?proj=182570 International Registered Report Identifier (IRRID)PRR1-10.2196/52820
first_indexed 2024-03-08T03:18:32Z
format Article
id doaj.art-4856f0b5fdcc4e19b02beb7b860f62a3
institution Directory Open Access Journal
issn 1929-0748
language English
last_indexed 2024-03-08T03:18:32Z
publishDate 2024-02-01
publisher JMIR Publications
record_format Article
series JMIR Research Protocols
spelling doaj.art-4856f0b5fdcc4e19b02beb7b860f62a32024-02-12T13:30:54ZengJMIR PublicationsJMIR Research Protocols1929-07482024-02-0113e5282010.2196/52820Cerebral Mechanism of Tuina on the Descending Pain Inhibitory System in Knee Osteoarthritis: Protocol for a Randomized Controlled TrialHui Xuhttps://orcid.org/0000-0002-1584-2804Zheng Wanghttps://orcid.org/0009-0008-5907-6946Zhen Wanghttps://orcid.org/0000-0002-0329-082XHang Zhouhttps://orcid.org/0009-0006-2616-6430Juan Guohttps://orcid.org/0009-0004-7779-9276Wanyu Lihttps://orcid.org/0009-0009-7359-1669Yunfeng Zhouhttps://orcid.org/0000-0002-5235-384X BackgroundKnee osteoarthritis (KOA) is reputedly the most common musculoskeletal disease of the lower limbs and the main cause of pain and disability among older individuals. Pain is the most significant and widespread symptom of KOA. The descending pain inhibitory system has a cardinal role in normal pain consciousness, and its malfunction may be one of the pathophysiological mechanisms in KOA. Crucially, the rostral ventromedial medulla (RVM) and periaqueductal gray (PAG), as important components of the descending pain inhibitory system, directly modulate the activity of the spinal neurons involved in pain transmission. Tuina, a manual therapy, is effective and safe for reducing clinical symptoms of KOA; however, the mechanism that influences pain through the descending pain inhibitory system in KOA is unclear. ObjectiveThis study aims to investigate the modulatory implications of Tuina on the RVM and PAG, which have critical roles in the descending pain inhibitory system in patients with KOA. MethodsThis randomized controlled parallel trial will be conducted at the Tuina Clinic of the Third Affiliated Hospital of Henan University of Chinese Medicine (Zhengzhou, China). Patients with KOA will be randomly assigned (1:1) to 6 weeks of health education or Tuina. All patients in both groups will accept a resting-state functional magnetic resonance scan at the beginning and end of the experiment, and the resting-state functional connectivity and the voxel-based morphometry analysis will be performed to detect the RVM and PAG function and structure changes. The clinical outcome assessments will be (1) the pressure pain thresholds, (2) the Numerical Rating Scale, (3) the Hamilton Depression Scale (HAMD), and (4) the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Considering that this trial is a study of resting-state functional magnetic resonance imaging technology, resting-state functional connectivity and voxel-based morphometry are the primary outcomes, and clinical outcome assessments are secondary outcomes. Adverse events will be documented and assessed throughout. All main analyses will be carried out on the basis of the intention-to-treat principle. The outcome evaluators and data statisticians will be masked to the treatment group assignment to reduce the risk of bias. ResultsThis trial was approved by the ethics committee of the Third Affiliated Hospital of Henan University of Chinese Medicine. Enrollment began in December 2023, and the results of this trial are expected to be submitted for publication in May 2025. ConclusionsThis trial will identify a possible relationship between function and structure changes of RVM and PAG and the improvement of clinical variables, elucidating the effect of Tuina on the descending pain inhibitory system of patients with KOA. This trial will provide much-needed knowledge for Tuina for patients with KOA. Trial RegistrationChinese Clinical Trial Registry ChiCTR2300070289; https://www.chictr.org.cn/showproj.html?proj=182570 International Registered Report Identifier (IRRID)PRR1-10.2196/52820https://www.researchprotocols.org/2024/1/e52820
spellingShingle Hui Xu
Zheng Wang
Zhen Wang
Hang Zhou
Juan Guo
Wanyu Li
Yunfeng Zhou
Cerebral Mechanism of Tuina on the Descending Pain Inhibitory System in Knee Osteoarthritis: Protocol for a Randomized Controlled Trial
JMIR Research Protocols
title Cerebral Mechanism of Tuina on the Descending Pain Inhibitory System in Knee Osteoarthritis: Protocol for a Randomized Controlled Trial
title_full Cerebral Mechanism of Tuina on the Descending Pain Inhibitory System in Knee Osteoarthritis: Protocol for a Randomized Controlled Trial
title_fullStr Cerebral Mechanism of Tuina on the Descending Pain Inhibitory System in Knee Osteoarthritis: Protocol for a Randomized Controlled Trial
title_full_unstemmed Cerebral Mechanism of Tuina on the Descending Pain Inhibitory System in Knee Osteoarthritis: Protocol for a Randomized Controlled Trial
title_short Cerebral Mechanism of Tuina on the Descending Pain Inhibitory System in Knee Osteoarthritis: Protocol for a Randomized Controlled Trial
title_sort cerebral mechanism of tuina on the descending pain inhibitory system in knee osteoarthritis protocol for a randomized controlled trial
url https://www.researchprotocols.org/2024/1/e52820
work_keys_str_mv AT huixu cerebralmechanismoftuinaonthedescendingpaininhibitorysysteminkneeosteoarthritisprotocolforarandomizedcontrolledtrial
AT zhengwang cerebralmechanismoftuinaonthedescendingpaininhibitorysysteminkneeosteoarthritisprotocolforarandomizedcontrolledtrial
AT zhenwang cerebralmechanismoftuinaonthedescendingpaininhibitorysysteminkneeosteoarthritisprotocolforarandomizedcontrolledtrial
AT hangzhou cerebralmechanismoftuinaonthedescendingpaininhibitorysysteminkneeosteoarthritisprotocolforarandomizedcontrolledtrial
AT juanguo cerebralmechanismoftuinaonthedescendingpaininhibitorysysteminkneeosteoarthritisprotocolforarandomizedcontrolledtrial
AT wanyuli cerebralmechanismoftuinaonthedescendingpaininhibitorysysteminkneeosteoarthritisprotocolforarandomizedcontrolledtrial
AT yunfengzhou cerebralmechanismoftuinaonthedescendingpaininhibitorysysteminkneeosteoarthritisprotocolforarandomizedcontrolledtrial